Recombinant Human Zinc transporter ZIP4 (SLC39A4)

What is the basic structure and function of human ZIP4 (SLC39A4)?

Human ZIP4 is a selective transporter predominantly mediating the uptake of Zn²⁺ ions across cellular membranes. Structurally, it contains:

• An N-terminal extracellular domain (ECD)

• 8 transmembrane domains forming the transport pathway

• Several cytosolic loops, particularly the second loop (L2) which contains important regulatory elements

• Histidine-rich regions in both the ECD and L2 that bind zinc with different affinities

Functionally, ZIP4 serves as the primary zinc uptake transporter in intestinal cells, though it also exhibits polyspecific binding and transport of other divalent metal ions including Cu²⁺, Cd²⁺, and possibly Ni²⁺ at higher concentrations . ZIP4's zinc uniporter activity is regulated by zinc availability, allowing cells to adjust zinc uptake according to nutritional status .

How does ZIP4 interact with other zinc transporters?

ZIP4 functions within the broader network of zinc homeostasis by interacting with other transporters including ZIP-1 and ZIP-10 . While direct physical interactions between these transporters haven't been extensively characterized, they operate in a coordinated manner to maintain proper cellular zinc levels. In experimental designs investigating ZIP4 function, researchers should consider:

• The expression levels of other zinc transporters that might compensate for ZIP4 modulation

• Using cell lines with minimal expression of other zinc transporters when isolating ZIP4-specific effects

• Employing specific inhibitors or RNAi approaches targeting multiple transporters to dissect their relative contributions

What are the mechanisms regulating ZIP4 expression and activity?

ZIP4 regulation occurs at multiple levels:

Transcriptional regulation:

• Activated during zinc deficiency

• Elevated in certain cancers, particularly hepatocellular carcinoma and pancreatic cancer

Post-translational regulation:

• Zinc-dependent endocytosis: At high zinc concentrations, ZIP4 is rapidly internalized from the cell membrane (occurs within minutes)

• Recycling: Under zinc-deficient conditions, internalized ZIP4 is recycled back to the cell surface

• Degradation: Prolonged high zinc exposure leads to ubiquitination and degradation of ZIP4

This multi-tiered regulation allows for both rapid adjustment (endocytosis/recycling) and long-term adaptation (transcriptional changes) to zinc availability.

How does zinc binding trigger ZIP4 endocytosis?

Zinc-dependent endocytosis of ZIP4 involves specific molecular mechanisms:

• Zinc sensing: The transport site within the transmembrane domain serves as the zinc sensor, with hZIP4 functioning as a "transceptor" (both transporter and receptor)

• Structural coupling: Zinc binding to the transport site induces conformational changes that couple to the second cytosolic loop (L2)

• Endocytic signal exposure: A conserved Leu-Gln-Leu (LQL) motif in L2 is required for ZIP4 endocytosis, likely becoming accessible to the endocytic machinery following zinc-induced conformational changes

Contrary to earlier hypotheses, the histidine-rich regions in the extracellular domain and the HxH motif in the transmembrane region do not significantly contribute to zinc sensing in human ZIP4, although there may be species-specific differences (e.g., in mouse ZIP4) .

How is ZIP4 involved in cancer progression?

ZIP4 has been implicated in multiple aspects of cancer biology:

Overexpression patterns:

• Dramatically elevated in hepatocellular carcinomas compared to surrounding tissues

• Overexpressed in pancreatic cancer, promoting tumor growth

• Potentially elevated in lymphoma, melanoma, and metastatic colon cancer according to database meta-analysis

Molecular mechanisms in cancer:

• Promotes pancreatic cancer invasiveness and metastasis by repressing tight junction proteins

• Establishes a signaling pathway involving:

  • Downregulation of ZO-1 and claudin-1 via the transcriptional repressor ZEB1

  • Subsequent upregulation of FAK and Paxillin phosphorylation

  • Enhanced cell migration and invasion

What genetic disorders are associated with ZIP4 mutations?

Mutations in ZIP4 (SLC39A4) can lead to a lethal genetic disorder known as Acrodermatitis enteropathica, characterized by:

• Severe zinc deficiency despite adequate dietary zinc intake

• Manifestations including dermatitis, alopecia, and diarrhea

• Growth retardation and immune dysfunction

Research approaches to study these mutations include:

• Expression of mutant ZIP4 in heterologous systems to assess zinc transport capacity

• Structure-function analyses to determine how specific mutations affect zinc binding, transport, or trafficking

• Cell-based assays to measure zinc uptake deficiencies associated with patient-derived mutations

What are the optimal methods for detecting ZIP4 expression in research samples?

Several complementary approaches can be used for ZIP4 detection:

Protein detection:

• Western blot: Using membrane preparation protocols with proper controls. ZIP4 appears as a ≈73 kDa band, often with larger aggregates also visible

• Immunohistochemistry: Effective for tissue sections, showing distinct localization patterns in normal versus diseased tissues

• Flow cytometry: Can be used to assess surface expression versus internalization

mRNA detection:

• Northern blot: Can reveal transcript levels in total RNA preparations

• qRT-PCR: For more sensitive quantification of transcript levels

• RNA-seq: For broader transcriptomic analysis including ZIP4 expression

When performing these assays, researchers should:

• Include appropriate controls (ZIP1 is often used as a membrane protein loading control)

• Consider zinc status of samples, as this affects ZIP4 expression and localization

• Use validated antibodies specific to the species being studied (human versus mouse ZIP4)

How can researchers effectively express and purify recombinant ZIP4 for in vitro studies?

Producing functional recombinant ZIP4 presents several challenges due to its multiple transmembrane domains. Recommended approaches include:

Expression systems:

• Mammalian cell lines: HEK293T cells have been successfully used

• Xenopus laevis oocytes: Effective for functional transport studies

• Yeast expression systems: For higher yield protein production

Purification strategies:

• Detergent solubilization: Critical for extracting membrane-embedded ZIP4

• Affinity tags: His-tags or FLAG-tags can facilitate purification

• Size exclusion chromatography: To separate monomeric from aggregated forms

Functional verification:

• Transport assays using radioisotope-labeled zinc or fluorescent zinc probes

• Binding assays for zinc and other potential substrates

• Structural integrity assessment through circular dichroism or limited proteolysis

How does the structural coupling between ZIP4's transport site and cytosolic loops regulate its endocytosis?

The zinc-dependent endocytosis of ZIP4 involves complex structural dynamics:

• Transport site as zinc sensor: Mutations in the transmembrane domain that disrupt zinc transport also impair zinc sensing for endocytosis, suggesting the transport pathway itself acts as the primary zinc sensor

• Conformational coupling: Partial proteolysis experiments with purified hZIP4 demonstrate structural coupling between the transport site and the second cytosolic loop (L2) upon zinc binding

• Signal exposure: The conformational change likely exposes the conserved LQL motif in L2, which serves as the endocytic signal

Advanced research approaches to further investigate this mechanism include:

• Cryo-EM studies of ZIP4 in different conformational states (with/without zinc)

• FRET-based assays to detect real-time conformational changes upon zinc binding

• Crosslinking studies to capture transient interaction states between the transport domain and cytosolic loops

What is the relationship between ZIP4's transport function and its role as a signaling molecule in cancer?

ZIP4 exhibits dual functionality as both a transporter and signaling molecule:

• Transport-dependent effects: Some oncogenic effects likely depend on increased zinc uptake, which may:

  • Activate zinc-dependent transcription factors

  • Influence metalloproteases involved in matrix remodeling and invasion

  • Alter cellular metabolism

• Transport-independent signaling: ZIP4 may also function as a transceptor, where:

  • Conformational changes upon zinc binding trigger signaling cascades

  • Interactions with other membrane or cytosolic proteins initiate downstream effects

  • ZIP4-mediated repression of ZO-1 and claudin-1 involves the transcriptional repressor ZEB1

Experimental approaches to distinguish these functions include:

• Using transport-deficient ZIP4 mutants to separate transport from signaling roles

• Investigating ZIP4 interactome under different zinc conditions

• Analyzing downstream signaling pathway activation with phosphoproteomic approaches

What are common challenges in ZIP4 knockdown/overexpression studies and how can they be addressed?

Researchers frequently encounter several issues when manipulating ZIP4 expression:

For knockdown studies:

• Incomplete knockdown: Use multiple RNAi sequences targeting different regions of ZIP4 mRNA

• Compensation by other zinc transporters: Consider dual knockdown approaches

• Cell viability issues: Monitor zinc supplementation requirements after ZIP4 knockdown

For overexpression studies:

• Protein aggregation: Optimize expression levels to avoid overloading cellular machinery

• Improper localization: Confirm membrane targeting using surface biotinylation or microscopy

• Functional verification: Always confirm transporter activity using zinc uptake assays

General considerations:

• Control for zinc levels in culture media, as they affect endogenous ZIP4 expression and localization

• Include appropriate vectors/scrambled controls for all genetic manipulations

• Validate antibodies for specificity, particularly when detecting overexpressed versus endogenous protein

How should researchers design experiments to study ZIP4's role in zinc homeostasis versus its involvement in pathological processes?

When investigating the dual roles of ZIP4, consider these methodological approaches:

For physiological zinc homeostasis studies:

• Use zinc depletion (using chelators like TPEN or Chelex-treated serum) and zinc supplementation to trigger regulatory responses

• Monitor both ZIP4 localization and expression levels in response to zinc changes

• Consider the temporal aspects of ZIP4 regulation (acute responses versus chronic adaptation)

For pathological process investigations:

• Compare ZIP4 expression between normal and disease tissues using paired samples when possible

• Correlate ZIP4 expression with clinical outcomes and disease progression markers

• Use genetic models (knockout/knockin) or xenograft models to assess causal relationships

Integrated approaches:

• Determine whether pathological effects are dependent on zinc transport by using transport-deficient mutants

• Investigate whether disease-associated mutations affect zinc homeostasis, trafficking, or both

• Consider compensatory mechanisms that might mask phenotypes in knockout models